A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma

British Journal of Cancer

Volumn 87, Issue 5, 2002, Pages 491-496

  Nowak, A K ^a,b   Byrne, M J ^a   Williamson, R ^b   Ryan, G ^a   Segal, A ^a   Fielding, D ^c   Mitchell, P ^d   Musk, A W ^a   Robinson, B W S ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

Cisplatin; Drug treatment; Gemcitabine; Malignant mesothelioma; Quality of life

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; THROMBOCYTOPENIA; VITAL CAPACITY; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOLOGIC DISEASES; HUMANS; LIFE TABLES; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037183683     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600505     Document Type: Article

References (32)

1. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
2. Combined cisplatin and gemcitabine for non-small cell lung cancer: Influence of scheduling on toxicity and drug delivery
3. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer
4. Gemcitabine (Gemzar) may reduce tumour load and tumour associated symptoms in malignant pleural mesothelioma
5. Cisplatin and gemcitabine treatment for malignant mesothelioma: A phase II study
6. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
7. Predictions of future cases of asbestos-related disease among former miners and millers of crocidolite in Western Australia
8. Combination raltitrexed (Tomudex)-oxaliplatin: A step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
9. One-sample multiple testing procedure for phase II clinical trials
10. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
11. Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B
12. Phase II trial of high-dose cisplatin in patients with malignant mesothelioma
13. Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients
14. Chemotherapy in malignant pleural mesothelioma. A review
15. Interaction between cisplatin and gemcitabine in vitro and in vivo
16. Preclinical combination therapy with gemcitabine and mechanisms of resistance
17. Continuing increase in mesothelioma mortality in Britain
18. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced non-small cell lung carcinoma
19. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer
20. A proposed new international TNM staging system for malignant pleural mesothelioma
21. A randomized phase III trial of four chemotherapy regimens in advanced non-small cell lung cancer (NSCLC)
22. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
23. The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer
24. Phase II study of vinorelbine in patients with malignant pleural mesothelioma
25. Advances in the treatment of malignant pleural mesothelioma
26. New guidelines to evaluate the response to treatment in solid tumours
27. Preliminary results of a phase I study with MTA (LY231514) in combination with cisplatin in patients with solid tumours
28. Multicenter phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma (MPM)
29. A phase II study of gemcitabine in patients with malignant pleural mesothelioma
30. Phase III randomized trial of onconase vs doxorubicin in patients with unresectable malignant mesothelioma
31. A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study